Shaping Europe's Future Creatively
20.1.2025 10:51:07 CET | news aktuell GmbH | Press Release
Europe-wide Call for Applications for the Emperor-Maximilian-Prize 2026 launched
The Emperor-Maximilian-Prize, endowed with 10,000 Euros, is awarded by the City of Innsbruck every two years to outstanding projects and initiatives that creatively and sustainably address current and future challenges of European society under the motto "young-european-united" – and confront these challenges together. Starting from January 22, 2025, nominations for the Emperor-Maximilian-Prize 2026 can be submitted across Europe.
"We are all Europe – only a shared identity defines this Europe. Therefore, we are very pleased to once again highlight creative initiatives from all over Europe with the Emperor-Maximilian-Prize this year. All of these projects carry forward the forward-thinking spirit of the European community. Because the challenges of tomorrow demand unconventional, creative solutions. We are happy to honor them with this prize!" invites Innsbruck's mayor, Johannes Anzengruber, the creative minds of Europe to submit their initiatives.
Young-European-United
In this year's Europe-wide call for applications for the Emperor-Maximilian-Prize, flagship projects are sought under the focus "young-european-united," which particularly provide role models for young people on how they can shape the future of European society. Initiatives that find creative, sustainable and joint solutions to the challenges of today and tomorrow can apply across municipal, regional, and national borders.
Submission Deadline: March 27
From January 22, 2025, projects for the Emperor-Maximilian-Prize 2026 can be submitted, with the submission deadline ending on March 27, 2025. Applications can be submitted via an online form in English at www.emperormaximilianprize.at. The application documents are available in 35 different languages. An experts jury will select the award winner in May 2025. The prize will be awarded in spring 2026 – including a prize money of 10,000 Euros for the winning project.
Contacts
Cornelia Kössler
Tel.: +43 512 53 60 2357
E-Mail: emperormaximilianprize@innsbruck.gv.at
Website: www.emperormaximilianprize.at
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
FEV analysis: TCO cut by up to 33 percent through range extender trucks11.2.2026 12:27:02 CET | Press Release
Aachen – FEV has published new analysis results on the economic efficiency of electrified commercial vehicles as part of an internal research program. The evaluation of extensive techno-economic data shows: depending on the driving cycle, through trucks with range extender architecture (REEV/Hybrid BEV) the total cost of ownership (TCO) can be reduced by up to 33 percent compared to conventional diesel trucks – while also significantly reducing CO₂ emissions. Even in the most unfavorable long-haul scenario, the TCO declined by approximately 14 percent.
BRP-Rotax: Aircraft Meets Racetrack – Luke Czepiela Flies the Racing Line at Bahrain International Circuit10.2.2026 17:00:00 CET | Press Release
BRP‑Rotax unveils its latest milestone in aviation with Aircraft Meets Racetrack. In an unprecedented accomplishment for the Bahrain International Circuit, Red Bull athlete and Rotax Ambassador Luke Czepiela became the first pilot to fly this Grand Prix track’s complete racing line from the air, showcasing the capabilities of Rotax powered aviation in a dramatic low‑level performance.
Grünenthal licenses exclusive Canadian rights to testosterone replacement therapy Nebido® to Apotex5.2.2026 16:03:03 CET | Press Release
Aachen, Germany & Toronto, Canada, February 5, 2026 – Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing agreement whereby Apotex will have the exclusive Canadian rights to Nebido® (testosterone undecanoate), a long-acting injectable therapy indicated for the treatment of male hypogonadism (testosterone deficiency).[1] [1] https://www.medicines.org.uk/emc/product/14631/smpc
HEIDELBERG achieves significant improvement in profitability after nine months of FY 2025/26 – strategic realignment proceeding as planned5.2.2026 08:02:33 CET | Press Release
Sales after nine months up on previous year, increasing by some 6.1 percent Adjusted EBITDA considerably better than in previous year – efficiency measures having a clear impact Incoming orders down on previous year, as expected, due to underlying economic conditions and absence of drupa effect Successful positioning in security, defense, and energy technologies Full-year forecast confirmed despite challenging environment
Between autonomy and alliance: Akkodis and POLITICO convene decision-makers for the future of AI made in Europe5.2.2026 07:56:35 CET | Press Release
First European Innovation & Tech Summit gathers leading technology experts from politics, industry and research in Brussels, focusing on AI as a bridge between human thinking and machine precision.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom